摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

p-tolyl 2,3,5-tri-O-benzoyl-1-thio-β-D-ribofuranoside | 918800-27-8

中文名称
——
中文别名
——
英文名称
p-tolyl 2,3,5-tri-O-benzoyl-1-thio-β-D-ribofuranoside
英文别名
1-(p-methylphenyl)-2,3,5-tri-O-benzoyl-1-thio-β-D-ribofuranose;p-methylphenyl-2,3,5-tri-O-benzoyl-1-thio-β-D-ribofuranose;[(2R,3R,4R,5S)-3,4-dibenzoyloxy-5-(4-methylphenyl)sulfanyloxolan-2-yl]methyl benzoate
p-tolyl 2,3,5-tri-O-benzoyl-1-thio-β-D-ribofuranoside化学式
CAS
918800-27-8
化学式
C33H28O7S
mdl
——
分子量
568.647
InChiKey
KXCPBCAUAAHJGN-LNHQPZRBSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    7.4
  • 重原子数:
    41
  • 可旋转键数:
    12
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.18
  • 拓扑面积:
    113
  • 氢给体数:
    0
  • 氢受体数:
    8

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

点击查看最新优质反应信息

文献信息

  • 3,5-Di(trifluoromethyl)phenyl(cyano)iodonium triflate as a novel and potential activator for <i>p</i>-tolyl thioglycoside donors
    作者:Xiaowei Tong、Zuowa Li、Boting Xi、Zhaoyan Wang、Yuan Li、Weihua Xue
    DOI:10.1039/d2ob01940j
    日期:——
    3,5-Di(trifluoromethyl)phenyl(cyano)iodonium triflate is described as an accessible, stable, and powerful thiophile that can activate batches of p-tolyl thioglycoside donors at room temperature. Various alcoholic acceptors were efficiently glycosylated, providing the desired glycosides. The novel activation protocol features mild conditions as well as high compatibility with some classic strategies
    3,5-二(三甲基)苯基(基)三氟甲磺酸盐被描述为一种易于获取、稳定且功能强大的亲试剂,可以在室温下激活一批对甲苯基苷供体。各种醇受体被有效地糖基化,提供所需的糖苷。新的激活协议具有温和的条件以及与一些经典策略的高度兼容性,用于一些生物学相关糖苷键的立体选择性构建,例如 α-idosides、α-galactoamines、β-mannosides 和 β-rhamnosides。
  • WO2007/113841
    申请人:——
    公开号:——
    公开(公告)日:——
  • Redesign of aminoglycosides for treatment of human genetic diseases caused by premature stop mutations
    作者:Igor Nudelman、Annie Rebibo-Sabbah、Dalia Shallom-Shezifi、Mariana Hainrichson、Ido Stahl、Tamar Ben-Yosef、Timor Baasov
    DOI:10.1016/j.bmcl.2006.09.013
    日期:2006.12
    A series of new derivatives of the clinically used aminoglycoside antibiotic paromomycin were designed, synthesized, and their ability to read-through premature stop codon mutations was examined in both in vitro translation system and ex vivo mammalian cultured cells. One of these structures, a pseudo-trisaccharide derivative, showed notably higher stop codon read-through activity in cultured cells compared to those of paromomycin and gentamicin. (c) 2006 Elsevier Ltd. All rights reserved.
查看更多